MDBriefCase will be unavailable due to maintenance from Sunday, January 14 11PM to Monday, January 15 1AM ET.

Welcome

Login
Join for Free
Register
Complete Needs Assessment Surveys For A Chance To Win! *Conditions Apply

RSV Prevention for All Infants

Monday, May 13th, 2024 | 7:00 PM - 8:00 PM ET

Duration – 1 hour

Register

Respiratory syncytial virus (RSV) is one of the most common respiratory viruses in infants and young children, infecting almost all children by two years of age. RSV is also the leading cause of infant hospitalizations in Canada, resulting in significant disease burden and impacts on the Canadian health system.

Considering the substantial burden of disease on all infants, NACI has recently issued new recommendations towards a universal RSV immunization program, with the use of nirsevimab to prevent severe RSV disease. In 2023, two new products were authorized by Health Canada for use in RSV immunization programs: nirsevimab, a long-acting monoclonal antibody, and RSVpref, a maternal vaccine. Nirsevimab is currently preferred over RSVpreF due to its higher efficacy and potential longer duration of protection.

This 60-minute webinar is designed to provide Canadian HCPs with practical information on passive immunization options available in Canada, with a focus on the newly authorized long-acting monoclonal antibody nirsevimab, and the maternal RSVpref vaccine.

The webinar will discuss RSV prevention through case studies, and highlight how a hospital order set can support implementation of the new RSV immunoprophylaxis in clinical practice.

Learning Objectives

  1. Describe the prevalence and burden of RSV disease in all infants
  2. Summarize NACI guidance and supporting evidence on passive immunization for RSV
  3. Implement an RSV prevention order set to support clinical practice

This webinar will feature:

marc-lebel-headshot

Marc Lebel

MD, FRCPC
taj-jadavji

Taj Jadavji

MD FRCPC FAAP
Erin Fleischer

Erin Fleischer

RN(EC) NP-Paediatrics, BScN, MN, CAE

Can’t attend? Register to receive a notification once the webinar is available on-demand.

Register today!

199 Bay Street #4000, Toronto,
ON M5L 1A9

Company
Help
Legal
Think Research Logo Green
© 2024. All Rights Reserved. Think Research Corporation.
Get Briefed

Author Agreement

In submitting your work (the “Work”) for potential posting on the MDBriefCase Healthcare Leadership Lab website (the “Website”), you (“You”) expressly agree to the following:

Review: MDBriefCase is pleased to consider the publication of Your Work on the Website.   The suitability of the Work for posting shall be determined by MDBRiefCase at its sole discretion. Nothing herein shall obligate MDBriefcase to post or otherwise publish the Work, or the maintain its posting in future.   

Editing; Identification: MDBriefcase shall have the right to edit the Work to conform to our standards of style, technological requirements, language usage, grammar and punctuation, provided that the meaning of the Work is not materially altered.  If posted, You will be identified as the author of the Work, or co-author if applicable.  

Grant of Rights:  As a condition of publication and for no monetary compensation, You hereby grant to MDBriefCase the following rights to the Work in any and all media whether now existing or hereafter developed, including print and electronic/digital formats:  (1) the exclusive right of first publication worldwide;  (2) the perpetual non-exclusive worldwide right to publish, reproduce, distribute, sell, adapt, perform, display, sublicense, and create derivative works, alone or in conjunction with other materials; (3) the perpetual non-exclusive worldwide right to use the Work, or any part thereof, in any other publication produced by MDBriefCase and/or on MDBriefCase’s website; and (4) the perpetual non-exclusive worldwide right to use the Work to promote and publicize MDBriefCase or its publications.  The grant of rights survives termination or expiration of this Agreement.    

Warranty:  You warrant that the Work is original with You and that it is not subject to any third party copyright; that You have authority to grant the rights in this Agreement; that publication of the Work will not libel anyone or infringe on or invade the rights of others; that You have full power and authority to enter into this Agreement; that the Work has not been published elsewhere in whole or in part; and that You have obtained permission from the copyright owner consistent with this Agreement for any third party copyrighted material in the Work.  This warranty survives termination or expiration of this Agreement.

Submission Agreement

Thank you for your interest in writing an article for the MDBriefCase Healthcare Leadership Lab website.

Audience and Appropriate Topics

The  Healthcare Leadership Lab welcomes submissions on all topics relevant to leaders in healthcare. Our topics include Leading in Healthcare, Leadership Lessons from COVID-19 and others. We prioritize stories that provide leadership advice to executives and managers in healthcare companies, offer actionable strategies for executing successful projects, and provide interesting angles on current healthcare topics. Submissions must be original work of the authors and unpublished.  When submitting, authors represent that they have included no material that is in violation of the rights of any other person or entity.

Parameters

Articles must be educational and non-promotional. If they mention the author’s company or any of the company’s products or services by name within the text, such mention should be very limited and used for reference only, not for promotion. (For example, an author might cite a survey conducted by his company but not describe his company’s product as a solution to a business problem.) Articles will be edited for clarity, style and brevity. The final headline is determined by the editor.

Length of Submissions

Guest articles for the MDBriefCase Healthcare Leadership Lab may run between 500 and 1000 words. 

Review

MDBriefCase reserves the right to accept or reject any submission  and the right to condition acceptance upon revision of material to conform to its criteria.   

No Compensation

There is no payment for contributed articles. However, MDBriefCase will give the author a byline. Authors are invited to link to the article on personal  websites, corporate websites and social media platforms.

Author Agreements

Each author understands and agrees that any submission accepted for posting is provided subject to MDBriefCase’s Author Agreement.